Cover Image
市場調查報告書

體外診斷市場:技術和全球市場

In Vitro Diagnostics: Technologies and Global Markets

出版商 BCC Research 商品編碼 345450
出版日期 內容資訊 英文 220 Pages
訂單完成後即時交付
價格
Back to Top
體外診斷市場:技術和全球市場 In Vitro Diagnostics: Technologies and Global Markets
出版日期: 2017年12月29日 內容資訊: 英文 220 Pages
簡介

全球體外診斷市場預測將從2017年的741億美元以年複合成長率6.7%擴大,到2022年前達到1,024億美元的規模。

本報告提供全球體外診斷市場相關調查,彙整市場概要和到2022年的成長預測,各用途,各終端用戶趨勢,及加入此市場的主要企業的簡介等資料。

第1章 簡介

第2章 摘要和亮點

第3章 市場情況

  • 市場概要與市場區隔

第4章 各產品區隔市場

  • 簡介
  • 詳細內容
    • 免疫化學
    • POC檢驗
    • 分子診斷
    • 血液學
    • 臨床微生物學
    • 組織診斷
  • IVD市場區隔趨勢
  • 競爭結構
    • 市場佔有率分析

第5章 全球免疫化學市場

第6章 全球POC檢驗市場

第7章 全球血液學市場

第8章 全球分子診斷市場

第9章 全球臨床微生物學市場

第10章 全球組織診斷市場

第11章 各終端用戶市場

第12章 IVD市場產品

第13章 各地區分析

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 國際醫療費與趨勢

第14章 新興技術與趨勢

  • 趨勢
  • 產業的發展
  • 機會領域

第15章 合併和收購

第16章 專利檢討

第17章 企業簡介

BCC 關於Research

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HLC186B

Report Highlights

The global in vitro diagnostics (IVD) market should reach $102.4 billion by 2022 from $74.1 billion in 2017 at a compound annual growth rate (CAGR) of 6.7%, from 2017 to 2022.

Report Includes:

  • 50 data tables and 9 additional tables
  • An overview of the global markets and related technologies for in vitro diagnostics.
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Detailed coverage of application areas, end users, and factors influencing and inhibiting demand for IVD.
  • Information about IVD products, including reagents, instruments, and data management software and services.
  • A look at how the rise in the number of diseases like respiratory infections, hospital acquired infections (HAI), and sexually transmitted diseases are creating a constant need for infectious disease testing in hospitals and laboratories.
  • Segmentation into immunochemistry, clinical chemistry, SMBG, POC, MDx, hematology, microbiology, hemostasis, and tissue diagnostics.
  • Application analysis: Diabetes, infectious, oncology, cardiology, and neurology.
  • Profiles of major players in the industry.

Report Scope

The scope of this study is global. BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, Korea, Taiwan, Africa, Australia, Brazil, and Russia, among others. The report also examines the IVD market drivers as well as restraints and challenges affecting its growth. Further, the report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the IVD industry through their best practices in the research and development of IVDs. Excluded from this study is diagnostic testing such as imaging, veterinary diagnostics and their associated products.

This study will provide information on these areas:

  • Structure and current market size of the IVD market as outlined with forecasts through 2022.
  • Impact of chronic diseases, growing and aging populations.
  • Current technology and product suppliers and key innovations.
  • A look at the IVD industry and trends affecting the market.
  • Markets by each segment (immunochemistry, molecular diagnostics, POC tests, clinical microbiology, hematology and tissue diagnostics) provide a global overview showing market data for the U.S., Europe, Asia-Pacific and Latin America, Africa and the Middle East (LAAM) regions.
  • Emerging opportunities and potential investment opportunity areas for IVD.
  • Technology patent trends relating to IVD.
  • Profiles for more than 20 companies in the industry with significant contributions and market shares.

Analyst Credentials

JON EVANS has been involved in business development and research for the biotechnology industry since 1984. He has been involved in sales, market research and strategy analysis with Fortune 500 clients - with a particular focus on business development challenges and strategies to optimize market performance. He holds a B.S. degree in biology from Rutgers University and MBA in business analysis from San Francisco State University.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Intended Readership
  • Scope of Report
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Global Market Trends

Chapter 3: Market Landscape

  • Market Overview and Segmentation
    • Key Findings
    • Factors Influencing the Global IVD Market
    • Challenges
    • Regulatory Landscape

Chapter 4: Market Breakdown by Product Segment

  • Introduction
  • Description
    • Immunochemistry
    • POC Testing
    • Molecular Diagnostics
    • Hematology
    • Clinical Microbiology
    • Tissue Diagnostics
  • Trends in IVD Segments
  • Competitive Structure
    • Market Share Analysis

Chapter 5: Global Immunochemistry Market

  • Applications
    • Blood Gas, Electrolytes and Metabolites (BGEM)
    • Endocrine
    • Infectious Diseases
    • Cancer
    • Urinalysis
    • Diabetes
    • Cardiology
    • Blood Screening
    • Others

Chapter 6: Global POC Testing Market

  • Applications
    • Glucose Testing
    • BGEM
    • Cardiac Marker Testing
    • Infectious Disease Testing
    • Pregnancy and Fertility Testing
    • Drug and Alcohol Abuse Testing
    • Hematology and Hemostasis Testing
    • Cholesterol Testing
    • Urine Chemistry Testing
    • Tumor Marker Testing
    • Other POC Testing

Chapter 7: Global Hematology Market

  • Applications
    • Routine Hematology Tests
    • Hemostasis

Chapter 8: Global Molecular Diagnostics Market

  • Applications
    • Infectious Diseases
    • Blood Screening
    • Oncology
    • Genetic Testing
    • Others (Companion Diagnostics, Prenatal Genetic Tests and Rare Diseases)

Chapter 9: Global Clinical Microbiology Market

  • Applications
    • Blood Culture
    • General Culture (urine/saliva/stool/sputum/CSF and other Body fluids)
    • Identification and Antibiotic Susceptibility Testing

Chapter 10: Global Tissue Diagnostics Market

  • Applications
    • Cancer Diagnosis
    • Tissue Typing
    • Pathogen Detection

Chapter 11: Market Breakdown by End Users

  • Introduction
  • Trends

Chapter 12: Global IVD Market Products

  • Introduction
  • Trends

Chapter 13: Regional Analysis

  • Introduction
  • North America
  • Europe
  • Asia-Pacific
  • LAAM
  • International Health Expenditure and Trends
    • North America
    • Europe
    • Western Europe
    • Central and Eastern Europe
    • Asia-Pacific
    • Latin America, Africa and Middle East (LAAM)

Chapter 14: Emerging Global Technology and Trends

  • Trends
  • Industry Developments
  • Opportunity Areas
    • IVD for Neglected Infectious Diseases
    • Portable Devices Compatible with Simple Detection Platforms
    • Chemistry-Based Portable Analyzers
    • Improved Sample Preservation Technologies
    • New Detection Technologies
    • Alternative Technologies to PCR
    • Key Biomarkers for Diseases of the Developing World
    • Microfluidic Platform-based POC Tests for Remote Settings
    • Combining Multiple Detection Technologies into a Single Instrument

Chapter 15: Mergers and Acquisitions

Chapter 16: Patent Review

  • Immunochemistry
  • Point of Care Testing
  • Molecular Diagnostics
  • Hematology
  • Clinical Microbiology
  • Tissue Diagnostics

Chapter 17: Company Profiles

  • Appendix
  • List of IVD Market Participants
  • List of Abbreviations

About BCC Research

  • About BCC Research
  • BCC Membership
  • BCC Custom Research

List of Tables

  • Summary Table: Global Market for In Vitro Diagnostics (IVD), by Region, Through 2022 ($ Millions)
    • Table 1 Types of Diagnostic Tests and How They Are Regulated
    • Table 2 Changes in IVD Regulations in Asia-Pacific, 2017
    • Table 3 Global IVD Market, by Segment, Through 2022 ($ Millions)
    • Table 4 Global IVD Market Share, by Major Market Companies, 2017 (%)
    • Table 5 Global Immunochemistry Market, by Application, Through 2022 ($ Millions)
    • Table 6 Global Immunochemistry Market, by Region, Through 2022 ($ Millions)
    • Table 7 Global POC Testing Market, by Application, Through 2022 ($ Millions)
    • Table 8 Global POC Testing Market, by Region, Through 2022 ($ Millions)
    • Table 9 Global Hematology Market, by Application, Through 2022 ($ Millions)
    • Table 10 Global Hematology Market, by Region, Through 2022 ($ Millions)
    • Table 11 Global Molecular Diagnostics Market, by Application, Through 2022 ($ Millions)
    • Table 12 Global Molecular Diagnostics Market, by Region, Through 2022 ($ Millions)
    • Table 13 List of Cleared or Approved Companion Diagnostic Devices, by Drug Trade Name (Generic)
    • Table 14 List of Cleared or Approved Human Genetic Tests
    • Table 15 Global Clinical Microbiology Market, by Application, Through 2022 ($ Millions)
    • Table 16 Global Clinical Microbiology Market, by Region, Through 2022 ($ Millions)
    • Table 17 List of FDA-Approved Microbial Tests, 2017
    • Table 18 Global Tissue Diagnostics Market, by Application, Through 2022 ($ Millions)
    • Table 19 Global Tissue Diagnostics Market, by Region, Through 2022 ($ Millions)
    • Table 20 Global IVD Market, by Region, Through 2022 ($ Millions)
    • Table 21 Global IVD Market Share, by Region, 2016-2022 (%)
    • Table 22 North American IVD Market, by Segment, Through 2022 ($ Millions)
    • Table 23 North American Immunochemistry Market by Segment, Through 2022 ($ Millions)
    • Table 24 North American POC Market, by Segment, Through 2022 ($ Millions)
    • Table 25 North American Hematology Market, by Segment, Through 2022 ($ Millions)
    • Table 26 North American Molecular Diagnostics Market, by Segment, Through 2022 ($ Millions)
    • Table 27 North American Microbiology Market, by Segment, Through 2022 ($ Millions)
    • Table 28 North American Tissue Diagnostics Market, by Segment, Through 2022 ($ Millions)
    • Table 29 European IVD Market, by Segment, Through 2022 ($ Millions)
    • Table 30 European Immunochemistry Market, by Segment, Through 2022 ($ Millions)
    • Table 31 European POC Market, by Segment, Through 2022 ($ Millions)
    • Table 32 European Hematology Market, by Segment, Through 2022 ($ Millions)
    • Table 33 European Molecular Diagnostics Market, by Segment, Through 2022 ($ Millions)
    • Table 34 European Microbiology Market, by Segment, Through 2022 ($ Millions)
    • Table 35 European Tissue Diagnostics Market, by Segment, Through 2022 ($ Millions)
    • Table 36 Asia-Pacific IVD Market Share, by Country, 2017 (%)
    • Table 37 Asia-Pacific IVD Market, by Segment, Through 2022 ($ Millions)
    • Table 38 Asia-Pacific Immunochemistry Market, by Segment, Through 2022 ($ Millions)
    • Table 39 Asia-Pacific POC Market, by Segment, Through 2022 ($ Millions)
    • Table 40 Asia-Pacific Hematology Market, by Segment, Through 2022 ($ Millions)
    • Table 41 Asia-Pacific Molecular Diagnostics Market, by Segment, Through 2022 ($ Millions)
    • Table 42 Asia-Pacific Microbiology Market, by Segment, Through 2022 ($ Millions)
    • Table 43 Asia-Pacific Tissue Diagnostics Market, by Segment, Through 2022 ($ Millions)
    • Table 44 LAAM IVD Market, by Segment, Through 2022 ($ Millions)
    • Table 45 LAAM Immunochemistry Market, by Segment, Through 2022 ($ Millions)
    • Table 46 LAAM POC Market, by Segment, Through 2022 ($ Millions)
    • Table 47 LAAM Hematology Market, by Segment, Through 2022 ($ Millions)
    • Table 48 LAAM Molecular Diagnostics Market, by Segment, Through 2022 ($ Millions)
    • Table 49 LAAM Microbiology Market, by Segment, Through 2022 ($ Millions)
    • Table 50 LAAM Tissue Diagnostics Market, by Segment, Through 2022 ($ Millions)
    • Table 51 IVD High-Complexity U.S. FDA Product Approvals, 2017
    • Table 52 Diagnostics Manufacturer Mergers and Acquisitions, 2004-2017
    • Table 53 Immunochemistry In vitro Diagnostics Patents Granted, 2016 and 2017
    • Table 54 POC In vitro Diagnostics Patents Granted, 2016 and 2017
    • Table 55 Molecular In Vitro Diagnostics Patents Granted, 2016 and 2017
    • Table 56 Hematology In Vitro Diagnostics Patents Granted, 2017 (First Three Quarters of the Year)*
    • Table 57 Clinical Microbiology In Vitro Diagnostics Patents Granted, 2016 and 2017
    • Table 58 Tissue In Vitro Diagnostics Patents Granted, 2016 and 2017
    • Table 59 Significant Companies Purchased by Thermo Fisher Scientific

List of Figures

  • Summary Figure: Global Market for In Vitro Diagnostics (IVD), by Region,2016-2022 ($ Millions)
    • Figure 1 Global IVD Market, by Segment, 2016-2022 ($ Millions)
    • Figure 2 Global IVD Market Share, by Segment, 2017 (%)
    • Figure 3 Global Immunochemistry Market Share, by Application, 2017 (%)
    • Figure 4 Global Immunochemistry Market, by Region, 2016-2022 ($ Millions)
    • Figure 5 Global POC Testing Market, by Application, 2016-2022 ($ Millions)
    • Figure 6 Global POC Testing Market, by Region, 2016-2022 ($ Millions)
    • Figure 7 Global Hematology Market, by Application, 2016-2022 ($ Millions)
    • Figure 8 Global Hematology Market Share, by Technique, 2017 (%)
    • Figure 9 Global Hematology Market Share, by System, 2017 (%)
    • Figure 10 Global Hematology Market, by Region, 2016-2022 ($ Millions)
    • Figure 11 Global Molecular Diagnostics Market, by Application, 2016-2022 ($ Millions)
    • Figure 12 Global Molecular Diagnostics Market Share, by Application, 2017 (%)
    • Figure 13 Global Molecular Diagnostics Market Share, by Infectious Disease, 2017 (%)
    • Figure 14 Global Molecular Diagnostics Market, by Region, 2016-2022 ($ Millions)
    • Figure 15 Global Clinical Microbiology Market, by Application, 2016-2022 ($ Millions)
    • Figure 16 Global Clinical Microbiology Market Share, by Application, 2017 (%)
    • Figure 17 Global Clinical Microbiology Market, by Region, 2016-2022 ($ Millions)
    • Figure 18 Global Tissue Diagnostics Market, by Application, 2016-2022 ($ Millions)
    • Figure 19 Global Tissue Diagnostics Market Share, by Application, 2017 (%)
    • Figure 20 Global Tissue Diagnostics Market, by Region, 2016-2022 ($ Millions)
    • Figure 21 Global IVD Market Share, by End User, 2017 (%)
    • Figure 22 Global IVD Market Share, by Product Type, 2017 (%)
    • Figure 23 Total Health Expenditure as a Percentage of GDP for the Top Industrialized Economies, 2015 (%)
    • Figure 24 European IVD Market Share, by Country, 2017 (%)
    • Figure 25 Western European IVD Market Share, by Country, 2017 (%)
    • Figure 26 Central and Eastern Europe IVD Market Share, by Country, 2017 (%)
    • Figure 27 Latin American IVD Market Share, by Country, 2017 (%)
    • Figure 28 Middle East and African IVD Market Share, by Region, 2017 (%)
Back to Top